Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/BL-1020> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- BL-1020 abstract "BL-1020 (perphenazine gamma-aminobutyrate) is an investigational orally-active antipsychotic for the possible treatment of schizophrenia, it's an ester of GABA and perphenazine, and pharmacologically it acts as a D2 antagonist and GABA agonist. It has shown pro-cognitive effects in the trials. In March 2013, it went into the II/III trial phase. It has been introduced by BioLineRx, a biopharmaceutical development company.".
- BL-1020 thumbnail Perphenazine_gamma-aminobutyrate.svg?width=300.
- BL-1020 wikiPageID "38584956".
- BL-1020 wikiPageLength "1520".
- BL-1020 wikiPageOutDegree "11".
- BL-1020 wikiPageRevisionID "704069701".
- BL-1020 wikiPageWikiLink Antipsychotic.
- BL-1020 wikiPageWikiLink BioLineRx.
- BL-1020 wikiPageWikiLink Category:5-HT2A_antagonists.
- BL-1020 wikiPageWikiLink Category:Antipsychotics.
- BL-1020 wikiPageWikiLink Category:D2_antagonists.
- BL-1020 wikiPageWikiLink Category:GABA_receptor_agonists.
- BL-1020 wikiPageWikiLink Gamma-Aminobutyric_acid.
- BL-1020 wikiPageWikiLink Perphenazine.
- BL-1020 wikiPageWikiLink Schizophrenia.
- BL-1020 wikiPageWikiLink File:Perphenazine_gamma-aminobutyrate.svg.
- BL-1020 wikiPageWikiLinkText "BL-1020".
- BL-1020 wikiPageUsesTemplate Template:Context.
- BL-1020 wikiPageUsesTemplate Template:GABAergics.
- BL-1020 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- BL-1020 wikiPageUsesTemplate Template:Reflist.
- BL-1020 subject Category:5-HT2A_antagonists.
- BL-1020 subject Category:Antipsychotics.
- BL-1020 subject Category:D2_antagonists.
- BL-1020 subject Category:GABA_receptor_agonists.
- BL-1020 type Page.
- BL-1020 comment "BL-1020 (perphenazine gamma-aminobutyrate) is an investigational orally-active antipsychotic for the possible treatment of schizophrenia, it's an ester of GABA and perphenazine, and pharmacologically it acts as a D2 antagonist and GABA agonist. It has shown pro-cognitive effects in the trials. In March 2013, it went into the II/III trial phase. It has been introduced by BioLineRx, a biopharmaceutical development company.".
- BL-1020 label "BL-1020".
- BL-1020 sameAs Q16964335.
- BL-1020 sameAs m.0r4w3_y.
- BL-1020 sameAs Q16964335.
- BL-1020 wasDerivedFrom BL-1020?oldid=704069701.
- BL-1020 depiction Perphenazine_gamma-aminobutyrate.svg.
- BL-1020 isPrimaryTopicOf BL-1020.